Latest Share Chat

CLIN.L Share News (CLIN)

CLIN.L Information

There is currently no data for CLIN

Thursday broker round-up

Thu, 23rd Jul 2020 14:25

(Sharecast News) - Stagecoach Group: Peel Hunt upgrades to buy with a target price of 70.0p.

Close Brothers Group: Berenberg reiterates hold with a target price of 1,170.0p.

Begbies Traynor Group: Canaccord reiterates buy with a target price of 122.0p.

Unilever: Liberum reiterates buy with a target price of 5,290.0p.

Getbusy: Liberum reiterates buy with a target price of 100.0p.

Clinigen Group: Peel Hunt downgrades to hold with a target price of 820.0p.

Strix Group: Peel Hunt reiterates buy with a target price of 205.0p.

Prudential: Deutsche Bank reiterates buy with a target price of 1,400.0p.

More News

1 Apr 2022 20:22

IN BRIEF: UK court sanctions Titon takeover of Clinigen

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says Thursday that its takeover by Triton Investment Management Ltd has been sanctioned by the High Court of Justice in England and Wales. Shares will be cancelled from trading on AIM on Tuesday.

23 Feb 2022 19:06

TRADING UPDATES: IPF swings to profit; Seraphine lowers outlook

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

23 Feb 2022 13:28

Clinigen revenue rises as shareholders approve its acquisition

(Sharecast News) - Pharmaceuticals and service company Clinigen Group reported a 10% improvement in net revenue from continuing operations in its half-year results on Wednesday, or 14% on an organic basis, to £238.1m.

16 Feb 2022 10:09

IN BRIEF: Clinigen expects acquisition by Triton to complete in April

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says its acquisition by funds managed by Triton Investment Management Ltd is likely to complete in early April, with its shares due to be cancelled on AIM on April 5. The deal and timeline are subject to antitrust and foreign investment approvals. Triton, a private equity firm submitted a cash offer of 925 pence per share, valuing Clinigen at GBP1.3 billion, which was approved by shareholders last Tuesday. The latest date for completion is September 8.

9 Feb 2022 10:38

IN BRIEF: Clinigen signs global distribution deal for Qinlock

8 Feb 2022 14:41

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

17 Jan 2022 10:05

Triton increases takeover bid for Clinigen to GBP1.3 billion

17 Jan 2022 07:29

Triton makes 'increased and final' 925p bid for Clinigen

(Sharecast News) - Clinigen announced an increased and final all-cash offer from Triton of 925p per share on Monday.

12 Jan 2022 11:49

Clinigen reiterates guidance after 'solid' first half

(Sharecast News) - Pharmaceutical products and services company Clinigen reiterated its guidance for EBITDA growth in the 2022 financial year of between 5% and 10% in a trading update on Wednesday.

12 Jan 2022 11:13